Are you Dr. Kisfalvi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 11 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
13400 E Shea Blvd
Scottsdale, AZ 85259Phone+1 904-953-2150
Summary
- Dr. Krisztina Kisfalvi, MD is an internist in Scottsdale, Arizona.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2012 - 2013
Publications & Presentations
PubMed
- 172 citationsEfficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis.William J. Sandborn, Filip Baert, Silvio Danese, Željko Krznarić, Taku Kobayashi
Gastroenterology. 2020-02-01 - 76 citationsEfficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial.Severine Vermeire, Geert R. D'Haens, Filip Baert, Silvio Danese, Taku Kobayashi
Journal of Crohn's & Colitis. 2021-08-17 - 242 citationsMetformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.Krisztina Kisfalvi, Guido Eibl, James Sinnett-Smith, Enrique Rozengurt
Cancer Research. 2009-08-15
